AM630 is a competitive cannabinoid receptor antagonist in the guinea pig brain

被引：46

作者：

Hosohata, K

Quock, RM

Hosohata, Y

Burkey, TH

Makriyannis, A

Consroe, P

Roeske, WR

Yamamura, HI

机构：

[1] UNIV ARIZONA, HLTH SCI CTR, COLL MED, DEPT PHARMACOL, TUCSON, AZ 85724 USA

[2] UNIV ARIZONA, HLTH SCI CTR, DEPT PHARMACOL & TOXICOL, TUCSON, AZ 85724 USA

[3] UNIV ARIZONA, HLTH SCI CTR, DEPT BIOCHEM, TUCSON, AZ 85724 USA

[4] UNIV ARIZONA, HLTH SCI CTR, DEPT PSYCHIAT, TUCSON, AZ 85724 USA

[5] UNIV ARIZONA, HLTH SCI CTR, PROGRAM NEUROSCI, TUCSON, AZ 85724 USA

[6] UNIV CONNECTICUT, SCH PHARM, STORRS, CT 06269 USA

[7] UNIV ILLINOIS, COLL MED, DEPT BIOMED SCI, ROCKFORD, IL 61107 USA

来源：

LIFE SCIENCES | 1997年 / 61卷 / 09期

关键词：

cannabinoid antagonist; S-35]GTP gamma S binding; guinea pig;

D O I：

10.1016/S0024-3205(97)00596-1

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

AM630 has been demonstrated to be a cannabinoid receptor antagonist in the mouse brain and vas deferens. Conversely, it was recently reported that AM630 acts as a cannabinoid agonist in the guinea pig ileum. This research was designed to determine whether the difference in the action of AM630 is species specific. Studies conducted in guinea pig brain reveal that AM630 antagonizes the stimulatory effect of the cannabinoid agonist WIN 55,212-2 on [S-35]GTP gamma S binding suggesting that difference in AM630 activity in different tissues is not due to species (C) 1997 Elsevier Science Inc.

引用

页码：PL115 / PL118

页数：4

共 50 条

[21] Inhibition of methamphetamine self-administration in rats by cannabinoid receptor antagonist AM 251
Vinklerová, J
Nováková, J
Sulcová, A
JOURNAL OF PSYCHOPHARMACOLOGY, 2002, 16 (02) : 139 - 143
[22] The cysteinyl-leukotriene receptor antagonist BAY u9773 is a competitive antagonist of leukotriene C-4 in the guinea-pig ileum
Back, M
Jonsson, EW
Dahlen, SE
EUROPEAN JOURNAL OF PHARMACOLOGY, 1996, 317 (01) : 107 - 113
[23] SR141716A, A POTENT AND SELECTIVE ANTAGONIST OF THE BRAIN CANNABINOID RECEPTOR
RINALDICARMONA, M
BARTH, F
HEAULME, M
SHIRE, D
CALANDRA, B
CONGY, C
MARTINEZ, S
MARUANI, J
NELIAT, G
CAPUT, D
FERRARA, P
SOUBRIE, P
BRELIERE, JC
LEFUR, G
FEBS LETTERS, 1994, 350 (2-3): : 240 - 244
[24] The CB2 ligand AM630 (6-iodopravadoline) increases the content and activity of pro-apoptotic markers in mouse brain
Alvaro-Bartolome, M.
Salort, G.
Garcia-Sevilla, J. A.
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2013, 23 : S195 - S195
[25] Identification of a presynaptic cannabinoid CB1 receptor in the guinea-pig atrium and sequencing of the guinea-pig CB1 receptor
Kurz, C. M.
Gottschalk, C.
Schlicker, E.
Kathmann, M.
JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2008, 59 (01): : 3 - 15
[26] Identification of a presynaptic cannabinoid CB1 receptor in the guinea-pig atrium and partial sequencing of the guinea-pig CB1 receptor
Schlicker, Eberhard
Kurz, Christina Maria
Kathmann, Markus
ACTA PHARMACOLOGICA SINICA, 2006, 27 : 104 - 104
[27] The cannabinoid receptor antagonist AM251 increases paraoxon and chlorpyrifos oxon toxicity in rats
Liu, Jing
Pope, Carey
NEUROTOXICOLOGY, 2015, 46 : 12 - 18
[28] The cannabinoid receptor antagonist AM-251 enhances the cerebrocortical hyperemic response to hypoxia/hypercapnia
Ishiguro, M
Lacza, Z
Horvath, EM
Jarai, Z
Sandor, P
Benyo, Z
FASEB JOURNAL, 2004, 18 (04): : A267 - A267
[29] Effect of cannabinoid receptor agonists on cholinergic neurotransmission in guinea-pig trachea.
Spicuzza, L
Patel, HJ
Venkatesari, P
Barnes, PJ
Belvisi, MG
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (03) : A536 - A536
[30] Treatment of Diet-Induced Obese Rats with CB2 Agonist AM1241 or CB2 Antagonist AM630 Reduces Leptin and Alters Thermogenic mRNA in Adipose Tissue
O'Keefe, Lannie
Vu, Teresa
Simcocks, Anna C. C.
Jenkin, Kayte A. A.
Mathai, Michael L. L.
McAinch, Andrew J. J.
Hutchinson, Dana S. S.
Hryciw, Deanne H. H.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (08)

← 1 2 3 4 5 →